4//SEC Filing
Zovighian Bernard J 4
Accession 0001225208-25-009840
CIK 0001099800other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 6:58 PM ET
Size
14.3 KB
Accession
0001225208-25-009840
Insider Transaction Report
Form 4
Zovighian Bernard J
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
2025-12-08$59.26/sh+25,350$1,502,157→ 106,326 total - Sale
Common Stock
2025-12-08$85.21/sh−21,487$1,831,006→ 84,839 total - Gift
Common Stock
2025-12-09−3,863→ 80,976 total - Sale
Common Stock
2025-12-10$83.45/sh−3,863$322,367→ 8,596.551 total(indirect: By Trust) - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2025-12-08−25,350→ 25,350 totalExercise: $59.26Exp: 2026-05-07→ Common Stock (25,350 underlying)
Holdings
- 3,605.849(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $84.63 to $85.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]These options were granted on May 8, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001665141
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 6:58 PM ET
- Size
- 14.3 KB